Related Experiment Videos
Mdm2 binds p73 alpha without targeting degradation
E Bálint1, S Bates, K H Vousden
1ABL Basic Research Program, NCI-FCRDC, Frederick, Maryland, 21702-1202, USA.
Abstract:
The function of the p53 tumor suppressor protein is regulated by interaction with Mdm2, which targets p53 for ubiquitin dependent degradation. We show here that like p53, p73 alpha forms an interaction with Mdm2, both in vitro and in cells, but this does not result in the degradation of the p73 alpha protein. The human papillomavirus E6 protein also fails to degrade p73 alpha, suggesting that the mechanisms governing p73 alpha stability are distinct from those known to regulate p53 stability. However, the interaction of Mdm2 with 73 alpha is sufficient to impede p73 alpha transcriptional function, despite the lack of degradation.
Insights
The tumor suppressor p73 alpha interacts with Mdm2, but unlike p53, it is not degraded. This interaction inhibits p73 alpha
Area of Science:
- Molecular Biology
- Cancer Research
- Tumor Suppressor Proteins
Background:
- The p53 tumor suppressor protein's function is regulated by Mdm2, leading to its degradation.
- Understanding the regulation of related proteins like p73 alpha is crucial for cancer research.
Purpose of the Study:
- To investigate the interaction between p73 alpha and Mdm2.
- To determine if Mdm2 binding affects p73 alpha stability and function.
- To compare the regulatory mechanisms of p73 alpha and p53.
Main Methods:
- In vitro binding assays.
- Cellular interaction studies.
- Analysis of protein degradation pathways.
- Transcriptional activity assays.
Main Results:
- p73 alpha forms an interaction with Mdm2 in vitro and in cells.
- This interaction does not lead to the degradation of p73 alpha.
- Human papillomavirus E6 protein also fails to degrade p73 alpha.
- Mdm2 binding impedes p73 alpha's transcriptional function despite the absence of degradation.
Conclusions:
- p73 alpha stability is regulated by mechanisms distinct from p53.
- Mdm2 interaction with p73 alpha inhibits its transcriptional activity without causing degradation.
- These findings shed light on the unique regulatory pathways of p73 alpha in cancer.